A new drug to treat Alzheimer’s Disease has been approved by Health Canada and it is the first drug that targets an ...

Lecanemab is the first medication approved in Canada that targets the buildup of amyloid plaque in the brain, which is ...

Earlier this year, two new drugs that have been shown in global trials to slow early-stage Alzheimer's disease, donanemab and lecanemab, were rejected by the Scottish Medicines Consortium (SMC), ...

Phase 3 clinical trial results of an investigational drug has shown benefits in treating people with APOE4/4 with early ...

Two widely available medicines can safely improve brain health in those with early Alzheimer’s disease, a new study has found ...

The approval of a new drug that can slow the progress of Alzheimer’s disease is being hailed as a historic moment in the ...

A new vitamin K-based treatment could help replenish lost neurons in Alzheimer's patients, offering hope for slowing ...

Health Canada recently authorized use of lecanemab, but experts say the drug is an incremental benefit, not a cure ...

After decades of unsuccessful research, two new drugs and a pioneering blood test have recently given Alzheimer's patients hope of fighting back against the debilitating disease - but questions remain ...

The diabetes drug empagliflozin (Jardiance) and an insulin nasal spray both showed promising effects on memory, brain health ...

The U.S. Food and Drug Administration has cleared another blood test that could help doctors identify whether memory problems ...

Labcorp, one of the country’s largest providers of diagnostic medical testing services, announced today that it will offer ...